Melissa Bochner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Melissa Bochner has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- R. Ainsworth
Breast, Endocrine and Surgical Oncology Unit, Royal Adelaide Hospital, Adelaide, 5000 SA, Australia
3 shared publications - James Kollias
University Department of Surgery, Royal Adelaide Hospital, South Australia, Australia
2 shared publications - R. Whitfield
Breast, Endocrine and Surgical Oncology Unit, Royal Adelaide Hospital, Adelaide, 5000 SA, Australia
2 shared publications - Brendon J. Coventry
University of Adelaide
1 shared publication D.M. Egbeare
1 shared publication- David Frederick Callen
Cancer Therapeutics Laboratory, Centre for Personalised Cancer Medicine, University of Adelaide, Australia
1 shared publication
Latest Publications
- Open Access
- 1 August 2014
- Published by Elsevier in The Breast
- Vol. 23 (4) , S4
The safety and efficacy of the sequence of treatments for locally advanced breast cancer patients undergoing mastectomy and immediate breast reconstruction
- 1 August 2014
- Published by Elsevier in The Breast
- Vol. 23 (4) , S4
Open AccessThe safety and efficacy of the sequence of treatments for locally advanced breast cancer patients undergoing mastectomy and immediate breast reconstruction
- Open Access
- 1 August 2014
- Published by Elsevier in The Breast
- Vol. 23 (4) , S3
Use of blue dye in sentinel lymph node biopsy: Time to reevaluate
- 1 August 2014
- Published by Elsevier in The Breast
- Vol. 23 (4) , S3
Open AccessUse of blue dye in sentinel lymph node biopsy: Time to reevaluate
- 1 June 2014
- Published by Elsevier in The Breast
- Vol. 23 (3) , 273-278
Influences on decision for mastectomy in patients eligible for breast conserving surgery
- 1 June 2014
- Published by Elsevier in The Breast
- Vol. 23 (3) , 273-278
Influences on decision for mastectomy in patients eligible for breast conserving surgery
- 29 June 2012
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 362 (1-2) , 202-210
A comparison of vitamin D activity in paired non-malignant and malignant human breast tissues
- 29 June 2012
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 362 (1-2) , 202-210
A comparison of vitamin D activity in paired non-malignant and malignant human breast tissues
- Open Access
- 28 October 2003
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 90 (11) , 1349-1353
Removal of two sentinel nodes accurately stages the axilla in breast cancer
Background Assessment of lymph node status in breast cancer is still necessary for staging. Sentinel lymph node biopsy (SNB) may provide accurate staging with less morbidity than axillary clearance. The aim of this study was to assess the effect of the number of sentinel nodes removed on the false-negative rate. Methods Data were collected prospectively from 395 women undergoing SNB for breast cancer, between June 1995 and December 2001. All nodes that were hot and/or blue were removed and analysed. Results During this interval 136 patients who had SNB were lymph node positive. The median number of sentinel nodes removed was two (range one to five). The overall false-negative rate of SNB in these women was 7·1 per cent. If only one sentinel node had been removed, the false-negative rate would have been 16·5 per cent. The removal of more than two nodes had no effect on axillary staging in all but two women. Conclusion In early breast cancer, when there were multiple sentinel nodes, removal of two sentinel nodes significantly reduced the false-negative rate compared with removal of one node. Removing more than two sentinel nodes did not significantly reduce the false-negative rate further.
- 28 October 2003
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 90 (11) , 1349-1353
Open AccessRemoval of two sentinel nodes accurately stages the axilla in breast cancer
Background Assessment of lymph node status in breast cancer is still necessary for staging. Sentinel lymph node biopsy (SNB) may provide accurate staging with less morbidity than axillary clearance. The aim of this study was to assess the effect of the number of sentinel nodes removed on the false-negative rate. Methods Data were collected prospectively from 395 women undergoing SNB for breast cancer, between June 1995 and December 2001. All nodes that were hot and/or blue were removed and analysed. Results During this interval 136 patients who had SNB were lymph node positive. The median number of sentinel nodes removed was two (range one to five). The overall false-negative rate of SNB in these women was 7·1 per cent. If only one sentinel node had been removed, the false-negative rate would have been 16·5 per cent. The removal of more than two nodes had no effect on axillary staging in all but two women. Conclusion In early breast cancer, when there were multiple sentinel nodes, removal of two sentinel nodes significantly reduced the false-negative rate compared with removal of one node. Removing more than two sentinel nodes did not significantly reduce the false-negative rate further.